GE HealthCare Technologies (GEHC) Total Current Liabilities (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Total Current Liabilities came in at $8.3 billion in Q2 2026, down 14.83% YoY from $9.7 billion in Q2 2025, and down 2.66% on a QoQ basis from $8.5 billion in Q1 2026.
GE HealthCare Technologies (GEHC) Total Current Liabilities (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Total Current Liabilities data on file, last reported at $8.3 billion in Q2 2026.
- Quarterly Total Current Liabilities fell 14.83% year-over-year to $8.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.3 billion (down 14.83% YoY) and the FY2025 annual result came in at $9.1 billion, down 4.69% from the prior year.
- Total Current Liabilities declined to $8.3 billion in Q2 2026, from $8.5 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $10.1 billion in Q3 2025 to a low of $7.2 billion in Q4 2022.
- A 5-year average of $8.7 billion and a median of $8.7 billion in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities grew 24.89% — and 2026, when it declined 14.83%.
- Tracing GEHC's Total Current Liabilities over 5 years: stood at $7.2 billion in 2022, then grew by 24.89% to $9.0 billion in 2023, then climbed by 6.37% to $9.6 billion in 2024, then decreased by 4.69% to $9.1 billion in 2025, then slipped by 8.82% to $8.3 billion in 2026.
- The last three Total Current Liabilities figures came in at $8.3 billion (Q2 2026), $8.5 billion (Q1 2026), and $9.1 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Zimmer Biomet Holdings | 19.23 Bn | 18.82 Bn | 1.54 Bn | 3.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.30 Bn |
| Mar 31, 2026 | 8.53 Bn |
| Dec 31, 2025 | 9.11 Bn |
| Sep 30, 2025 | 10.07 Bn |
| Jun 30, 2025 | 9.75 Bn |
| Mar 31, 2025 | 9.97 Bn |
| Dec 31, 2024 | 9.55 Bn |
| Sep 30, 2024 | 8.67 Bn |
| Jun 30, 2024 | 8.32 Bn |
| Mar 31, 2024 | 8.86 Bn |
| Dec 31, 2023 | 8.98 Bn |
| Sep 30, 2023 | 7.57 Bn |
| Jun 30, 2023 | 7.58 Bn |
| Mar 31, 2023 | 8.24 Bn |
| Dec 31, 2022 | 7.19 Bn |